Bank Of New York Mellon Corp Embecta Corp. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$23.07 - $32.77 $23.9 Million - $33.9 Million	1,035,910 New	1,035,910 $29.1 Billion
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $30.9 Million - $43.3 Million	1,221,302 New	1,221,302 $30.9 Million
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $243,048 - $338,444	-10,127 Reduced 0.98%	1,026,158 $29.5 Million
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $25.7 Million - $34.6 Million	1,036,285 New	1,036,285 $26.2 Million

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.